RCMI Coordinating Center (RCMI CC) Header Logo

Connection

J Goodwin to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications J Goodwin has written about Dose-Response Relationship, Drug.
J Goodwin
Connection Strength
0.208
Dose-Response Relationship, Drug
  1. Ninan MJ, Liu Y, Kuo YF, Goodwin JS. Hospitalization for Toxicity in Patients Treated With Rituximab. Am J Clin Oncol. 2017 Apr; 40(2):125-132.
    View in: PubMed
    Score: 0.105
  2. Goodwin JS, Zhou J, Kuo YF, Baillargeon J. Risk of Jaw Osteonecrosis After Intravenous Bisphosphonates in Cancer Patients and Patients Without Cancer. Mayo Clin Proc. 2017 Jan; 92(1):106-113.
    View in: PubMed
    Score: 0.103
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support